CompletedPhase 2NCT00002982

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma

Studying Anaplastic large cell lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Memorial Sloan Kettering Cancer Center
Principal Investigator
Craig Moskowitz, MD
Memorial Sloan Kettering Cancer Center
Intervention
filgrastim(biological)
Eligibility
60 years · All sexes
Timeline
1997 – 2005

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00002982 on ClinicalTrials.gov

Other trials for Anaplastic large cell lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Anaplastic large cell lymphoma →

← Back to all trials